Virtual GP clinics – are they accessible as they need to be?As the the pandemic accelerates a move towards remote doctors appointments, work still needs to be done to Share XVirtual GP clinics – are they accessible as they need to be?https://pharmaphorum.com/digital/virtual-clinics-are-they-accessible-as-they-need-to-be/
What HCPs think about health equity in cancer careAfter more than a year of COVID-19 dominating health conversations, HCPs have been engaging in dialogue about continually Share XWhat HCPs think about health equity in cancer carehttps://pharmaphorum.com/views-and-analysis/what-hcps-think-about-health-equity-in-cancer-care/
Digital health developments: a new investment era for start-upsHealthware Labs’ Kristin Milburn explores how digital health start-ups can harness the huge potential for the sector in Share XDigital health developments: a new investment era for start-upshttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/digital-health-developments-a-new-investment-era-for-start-ups/
Health Innovators – Jo Brewer, AdaptimmuneIn this episode of Health Innovators, pharmaphorum founder Paul Tunnah interviews Jo Brewer, senior vice president of allogeneic Share XHealth Innovators – Jo Brewer, Adaptimmunehttps://pharmaphorum.com/video/health-innovators-jo-brewer-adaptimmune/
Why pharma needs a revolution in cultureJames Dempsey breaks down the misconception that culture can’t be measured, and gives tips for how companies can Share XWhy pharma needs a revolution in culturehttps://pharmaphorum.com/sales-marketing/why-pharma-needs-a-revolution-in-culture/
NICE feedback?The National Institute for Health and Care Excellence (NICE) is quite far along a NICE-led process to review Share XNICE feedback?https://pharmaphorum.com/views-and-analysis/nice-feedback/
Why pharma shouldn’t forget about sites in a post-COVID worldThe pandemic forced massive changes to oncology sites to ensure patient safety and research continuity – but we Share XWhy pharma shouldn’t forget about sites in a post-COVID worldhttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/why-pharma-shouldnt-forget-about-sites-in-a-post-covid-world/
Taking steps towards a data-driven future for health and social careA new policy paper promises to make it easier for innovators and developers to build and deploy tech Share XTaking steps towards a data-driven future for health and social carehttps://pharmaphorum.com/views-and-analysis/taking-steps-towards-a-data-driven-future-for-health-and-social-care/
How digital pathways are changing healthcareAs demonstrated throughout COVID, digital health is no longer experimental. Digital technologies are proving their value by allowing Share XHow digital pathways are changing healthcarehttps://pharmaphorum.com/digital/how-digital-pathways-are-changing-healthcare/
